Appen (APX) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
27 Aug, 2026Executive summary
H1 FY2026 revenue reached $119.9 million, up 17.5% year-over-year, driven by 80% growth in Appen China and stabilization in Appen Global's traditional business.
Appen China delivered standout performance with revenue of $76.2 million (+80% year-over-year), annualized run rate exceeding $175 million by June, and underlying EBITDA up 316% to $12.1 million.
Underlying EBITDA before FX improved by $7.5 million to $5.3 million, with EBITDA margin at 4.5%.
Statutory net loss after tax narrowed to $4.4 million from $19.3 million in H1 FY2025.
Cash balance at period end was $44.7 million, with no debt.
Financial highlights
Group revenue increased 17.5% to $119.9 million compared to H1 FY2025.
Appen China revenue grew 80.4% to $76.2 million; Appen Global revenue declined 26.9% to $43.7 million.
Gross margin slightly decreased by 30 basis points to 36.7% due to customer and project mix.
Underlying NPAT improved by $8 million to $(4.2) million; statutory NPAT improved to $(4.4) million.
No interim dividend declared for the period.
Outlook and guidance
FY2026 group revenue guidance reaffirmed at $270 million–$300 million, with underlying EBITDA before FX margin expected between 5%–10%.
Positive signals for LLM-related growth in both Appen Global and Appen China; seasonality expected to skew revenue towards H2.
Focus remains on high data quality, customer growth in high-potential segments, and operational efficiency.
No additional funds required to support growth; current cash reserves deemed sufficient until self-sustainability.
Latest events from Appen
- FY25 revenue and EBITDA surged, led by generative AI and China, with FY26 growth guidance set.APX
AGM 2026 - Q1 FY26 revenue up 9% year-over-year, led by Appen China's 88% growth and strong AI demand.APX
Q1 2026 TU - FY25 saw 4.5% revenue growth, 75% China surge, and margin gains; FY26 outlook is strong.APX
H2 2025 - Q4 FY25 revenue and EBITDA surged on generative AI and China growth, with strong cash gains.APX
Q4 2025 TU - H1 revenue $102.1M, China up 67%, net loss $19.3M, FY25 guidance and positive EBITDA reaffirmed.APX
H1 2025 - Raised A$55m to fund generative AI growth, with Q3 revenue up 34.6% ex-Google and EBITDA positive.APX
Capital Raise - Revenue down 18%, but cost cuts and generative AI drove improved profitability.APX
H1 2024 - Profitability restored, China and AI growth strong, with 2025 focused on tech and efficiency.APX
AGM 2025 - Profitability restored as generative AI and China drive growth, despite Google contract loss.APX
H2 2024